Luca Roncati | Pharmacovigilance | Best Academic Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Luca Roncati | Pharmacovigilance | Best Academic Researcher Award

Link Campus University | Italy

Prof. Dr. Luca Roncati is a distinguished Italian pathologist, physician-scientist, and academic leader whose extensive contributions have significantly advanced modern medical science. With a strong focus on senology, gynecologic oncology, gynecopathology, and hematopathology, he stands as a prominent figure in the global medical community. Dr. Roncati has an impressive record of 228 scientific publications, collectively cited in over 1,073 documents with more than 1,738 total citations, reflecting the profound influence and credibility of his research across various medical disciplines.Renowned for his groundbreaking discoveries, Dr. Roncati is the eponym of the Roncati–Manenti Triad, a key diagnostic concept in gynecologic oncology, and the describer of T rex lymphoma, a rare hematological condition that broadened the understanding of lymphoid malignancies. As a pioneering researcher in COVID-19, his investigations provided critical insights into viral pathogenesis and immune mechanisms, shaping the scientific response during the global pandemic. Furthermore, his innovative work in nanopathology has paved the way for the integration of nanotechnology into modern diagnostic pathology, offering revolutionary approaches to disease detection at the molecular level.Beyond research, Dr. Roncati is a full-time Professor of Pathology at Link Campus University in Rome, where he mentors future medical professionals and drives forward-thinking educational programs in biomedical sciences. Simultaneously, he leads as the Head of the Women’s Health Department at the European Institute of Dermatology in Milan, where his expertise in women’s health, oncology, and diagnostic pathology enhances patient care and clinical outcomes.An award-winning author, academic editor, and inventor of anti-cancer patents, Dr. Roncati’s contributions exemplify the synergy between innovation, clinical excellence, and scientific discovery. His scholarly achievements, coupled with his dedication to advancing medical knowledge, have established him as one of the most influential figures in contemporary pathology and translational medicine. Through his research, publications, and leadership, Prof. Dr. Luca Roncati continues to inspire a new generation of scientists and clinicians in their pursuit of excellence and innovation in healthcare.

Profile: Scopus

Featured Publications

Roncati, L., et al. (2025). Erratum: Long COVID clinical evaluation, research and impact on society: a global expert consensus. Annals of Clinical Microbiology and Antimicrobials.

Roncati, L., et al. (2025). Long COVID clinical evaluation, research and impact on society: a global expert consensus. Annals of Clinical Microbiology and Antimicrobials.

Roncati, L., et al. (2025). pDNA impurities in mRNA vaccines. Editorial, Open Access.

Roncati, L., et al. (2025). Thoracic aortic pseudoaneurysm: Inside its pathophysiology. Vascular.

Roncati, L., et al. (2025). Adjuvant metronomic chemotherapy after surgery in pT1–T2 N0 M0 HER2-positive and ER/PR-positive breast cancer plus targeted therapy, anti-hormonal therapy, and radiotherapy, with or without immunotherapy: A new operational proposal. Editorial, Open Access.

Roncati, L., et al. (2025). Ozone–oxygen therapy to prevent HPV-related cancers of the lower gynecological tract in infected patients: The rationale for further developments. Cancers. [Open Access]

Roncati, L., et al. (2025). COVID-19 and upper limb compression neuropathies: A review. Review Article, Open Access.

Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Staff Neonatologist and Developmental Pediatrician at University of Toronto | Canada

Dr. Kamini Raghuram is a clinician-scientist specializing in developmental and behavioral pediatrics, neonatal-perinatal medicine, and clinical epidemiology. With a strong foundation in pediatrics, she has combined clinical expertise with cutting-edge research to advance outcomes in high-risk and preterm infants. Her work bridges clinical practice, epidemiology, and innovative technological tools such as automated video-based analysis for motor impairment. Dr. Raghuram has been a principal and co-investigator on numerous funded projects and has published extensively in leading pediatric and neonatal journals. She is widely recognized for her dedication to improving long-term neurodevelopmental outcomes in vulnerable infant populations.

Publication Profile 

Orcid

Education 

Dr. Kamini Raghuram completed her Doctor of Medicine (MD) at the University of Toronto, followed by FRCPC training in General Pediatrics, Neonatal and Perinatal Medicine, and Developmental and Behavioral Pediatrics at the same institution. She earned a Master of Science in Clinical Epidemiology and Health Care Research from the Institute of Health Policy, Management, and Evaluation, University of Toronto, where her thesis focused on video-based motor impairment analysis in preterm infants. Earlier, she obtained a Bachelor of Applied Science in Chemical and Biological Engineering from the University of British Columbia, graduating as class valedictorian and recognized for outstanding research proficiency.

Experience 

Dr. Kamini Raghuram has held extensive clinical and academic positions across pediatrics, neonatology, and developmental medicine. She has served as a clinician-investigator, integrating patient care with translational research to develop evidence-based approaches for preterm infants. Her work includes leading clinical trials, advancing quality improvement initiatives, and applying machine learning and automated video analysis for early detection of motor and neurodevelopmental impairments. With expertise spanning neonatal intensive care, developmental follow-up, and health outcomes research, she has collaborated nationally and internationally to improve clinical pathways for high-risk infants. Her experience reflects a unique combination of bedside practice and pioneering research in pediatrics.

Awards and Honors 

Dr. Kamini Raghuram has received numerous awards and funding recognitions for her research and clinical excellence. These include CIHR grants exceeding $2 million, innovation fund competitions, and recognition for her work on neonatal outcomes. She has won presentation and research awards at the University of Toronto, The Hospital for Sick Children, and international conferences. Honors such as the Excellence in Academic Coaching Award, Quality Improvement Award, Canada Graduate Scholarship, and early-career fellowships highlight her leadership and academic impact. Earlier, as an engineering student, she received the Lefevre Gold Medal and delivered the valedictorian address at the University of British Columbia.

Research Focus 

Dr. Kamini Raghuram research focuses on improving neurodevelopmental and health outcomes in preterm and high-risk infants through early detection, intervention, and long-term follow-up strategies. She applies advanced tools, including automated video analysis, MRI biomarkers, and large-scale database studies, to identify predictors of motor and cognitive impairment. Her work integrates clinical epidemiology with neonatal and developmental pediatrics, emphasizing translational approaches from bench to bedside. She is also involved in clinical trials addressing interventions such as coadministration therapies and surgical decision-making in fetal medicine. Her ultimate goal is to enhance early diagnosis, optimize interventions, and improve quality of life for vulnerable children.

Publication Top Notes

Caregiver Experiences, Healthcare Provider Perspectives and Child Outcomes with Virtual Care in a Neonatal Neurodevelopmental Follow-Up Clinic: A Mixed-Methods Study

Automated Movement Analysis to Predict Cerebral Palsy in Very Preterm Infants: An Ambispective Cohort Study

Conclusion

Dr. Kamini Raghuram is a highly deserving candidate for the Best Researcher Award. Her career reflects a rare combination of clinical excellence, research innovation, and dedication to improving outcomes for preterm infants. With substantial grant funding, groundbreaking studies in automated movement analysis, and leadership in advancing neonatal care, she exemplifies the qualities of a leading researcher. While opportunities exist to expand her global influence and further scale her innovations, her proven track record of impactful, patient-centered research makes her an outstanding nominee for this prestigious recognition.

Dhanpat Sharma | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dhanpat Sharma | Drug Safety and Risk Management | Best Researcher Award

Dr. Dhanpat Sharma, Central University of Haryana, India

Dr. Dhanpat Sharma is a passionate physicist who recently submitted his Ph.D. thesis at the Central University of Haryana, India, focusing on the generation of magnetic fields during heavy ion collisions. His work bridges theoretical simulations with experimental studies involving low-intensity magnetic fields for environmental applications. He has published extensively on photocatalysis, nanomaterials, and nuclear physics. Dr. Sharma is a recipient of multiple prestigious fellowships, including UGC-CSIR NET-JRF and GATE, and has actively presented his research at national and international conferences. His innovative insights continue to contribute significantly to nuclear and materials science.

Publication Profile

orcid

Education

Dr. Dhanpat Sharma 🎓 is a dedicated physicist currently pursuing his Ph.D. in Physics at the Central University of Haryana, Mahendergarh, India, from August 2019 to April 2025. His research, guided by Prof. Suneel Kumar, focuses on the study of nuclear flow, nuclear stopping, magnetic fields, and their inter-correlations in heavy ion collisions ⚛️. He earned his M.Sc. in Physics from Maharishi Dayanand University, Rohtak, between 2016 and 2018 📘. Prior to that, he completed his B.Sc. in Physics, Chemistry, and Mathematics at Kirori Mal College, University of Delhi 🎓, from 2012 to 2016, laying a strong foundation for his scientific journey.

Experience

Dr. Dhanpat Sharma 💻 has hands-on experience in coding within the Quantum Molecular Dynamics (QMD) and Isospin-dependent Quantum Molecular Dynamics (IQMD) frameworks, which are essential tools for simulating heavy ion collisions at intermediate energies ⚛️. His work involves implementing and modifying simulation codes to analyze nuclear flow, nuclear stopping, and magnetic field effects. Through this expertise, Dr. Sharma has gained a deep understanding of the computational modeling of complex nuclear interactions 🧠. His coding proficiency allows him to conduct high-level theoretical research, contributing significantly to the field of nuclear physics 🔬, and enhancing predictive accuracy in nuclear collision studies.

Awards

Dr. Dhanpat Sharma 🏅 has been recognized for his academic excellence with several prestigious awards and honors. He qualified the UGC-CSIR NET-JRF twice, in December 2018 and July 2019, earning a fellowship for his Ph.D. studies 🎓. Additionally, he cleared the GATE exam in February 2019, further showcasing his strong command in physics 📘. Dr. Sharma also qualified for the IGCAR entrance with an impressive All India Rank of 34 🔬. Demonstrating consistent academic merit, he secured the 4th rank in the Ph.D. entrance test conducted by the University of Delhi, solidifying his position among top research scholars in India 🇮🇳.

Research Focus

Dr. Dhanpat Sharma focuses on magneto-photocatalysis, heavy-ion collision physics, and advanced nanomaterials for energy and environmental applications. His research spans the development of photocatalytic materials like α-γ-Fe₂O₃/rGO for antibiotic degradation 💊, to synthesizing nanocomposites for energy storage ⚡ using waste-derived Fe₃O₄. In nuclear physics, he explores the evolution of magnetic and electromagnetic fields 🧲 during heavy-ion collisions, studying correlations with nuclear stopping and elliptical flow. His interdisciplinary expertise bridges materials science, nuclear theory, and applied nanotechnology 🧪, addressing both sustainable tech and fundamental particle interactions in extreme conditions.

Publication Top Notes

Magnetic field and dissolved oxygen assisted ultra-high photocatalytic activity of α-γ-Fe2O3 heterophase wrapped with rGO sheets for the removal of rifampicin

Waste toner derived Fe3O4 nanoparticles embedment into PANI matrix as an advanced electrode for supercapacitor

Probing the contribution of various mass fragments in the production of magnetic field during heavy ion collisions

Correlation between elliptical flow and nuclear stopping around the transition energy in mid rapidity zone

Influence of symmetry energy on electromagnetic field during heavy-ion collisions
Correlation between magnetic field and nuclear stopping in different rapidity segments during heavy ion collisions
Production of magnetic field due to heavy ion collisions around transition energy